Offering being developed
Pharma market access
We aim to bring market access into our pharma consulting vision. This activity is being developed: expertise, sources and scope must be qualified before any engagement.
Topics to scope together
- Clarify the country, product and access question
- Map available information and missing data
- Identify the specialist expertise required
Scope and limits
We do not have proprietary market access data. Commercial and competitive intelligence does not replace a market access study. We do not claim HTA, health economic or reimbursement negotiation expertise without verified capabilities.
Possible deliverable, subject to agreement
A brief defining needs, required sources and expertise to secure, subject to scope validation.
Discuss this topic